The expression of CBX1, CBX2, CBX5, and CBX8 significantly positively correlates with cancer stemness in LIHC, LUAD, and UCEC tumors, while CBX6—negatively associates with cancer stemness in LUAD and PAAD tumors. Here, CBX1 is linked to pancreatic adenocarcinoma.